Betsy Reese, DO
Sports Medicine · Draper, UTNPI 1477817443
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 182 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 43 manufacturers, the largest accounting for just 15.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $959 and has fallen 97.3% since, to $25 in 2025.
Across 182 payments — averaging $16.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$459
- AbbVie$250
- Boehringer Ingelheim$202
- Lilly USA, LLC$158
- Boston Scientific$152
- Novo Nordisk$131
- plus $2K from 37 others
What the payments were for
- Food & beverage$3,013100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$3,013 in reported general payments places this provider in the 70th percentile of 83 sports medicine providers in Utah.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 31 | $29,984 |
| EliquisApixaban | 33 | $28,443 |
| TrulicityDulaglutide | 18 | $27,911 |
| MounjaroTirzepatide | 20 | $23,395 |
| JardianceEmpagliflozin | 13 | $13,781 |
| MyrbetriqMirabegron | 12 | $13,261 |
| Xigduo XrDapaglifloz Propaned/Metformin | 13 | $12,161 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 12 | $11,398 |
| SymbicortBudesonide/Formoterol Fumarate | 15 | $7,649 |
| Combivent RespimatIpratropium/Albuterol Sulfate | 12 | $5,775 |
| Estradiol | 37 | $2,462 |
| Omeprazole | 149 | $2,355 |
| Ezetimibe | 35 | $2,062 |
| SynthroidLevothyroxine Sodium | 30 | $2,037 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 59 | $1,843 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCTrulicity, Mounjaro | $158 | $51,30638 claims |
| Novo NordiskOzempic | $131 | $29,98431 claims |
| PfizerEliquis | $57 | $28,44333 claims |
| Boehringer IngelheimJardiance, Combivent Respimat | $202 | $19,55525 claims |
| Astellas Pharma US IncMyrbetriq | $103 | $13,26112 claims |
| GSKTrelegy Ellipta | $109 | $11,39812 claims |
| AstraZenecaSymbicort | $51 | $7,64915 claims |
| AbbVieSynthroid | $250 | $2,03730 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 83 sports medicine providers in Utah.
Other sports medicine in Draper
- Charles BeckDraper$157K
- Andrea MatichDraper$515
- Thomas RosenbergPark City$5.5M
- Colby BarberSt George$61K
- Philip DavidsonPark City$60K
- Sean DavisOgden$60K
- Trevor SheltonProvo$43K
- Gary EdwardsLehi$39K
- Seth CopeWest Point$27K
- Kade LymanMonticello$26K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.